Meet the Team

Dr. Alinari is a hematologist who specializes in treating and studying lymphoid malignancies. His research focuses on identifying novel therapeutic targets as well as on developing innovative preclinical and clinical treatment strategies for patients with lymphoma.

Jessica manages not only the Alinari Lab, but also the Baiocchi Lab and works with other collaborating labs. In her role, she handles all onboarding and inventory upkeep and assists with daily administrative duties. Jessica strives to assist with tackling the complexities of cancer research by building a team atmosphere where solutions are created. A native of central Ohio, Jessica earned her BS in biology from The Ohio State University.

Dr. Sloan works on developing novel CAR T-cell products for the treatment of classical Hodgkin lymphoma. She received her PhD from The Ohio State University.

Dr. Pray’s project involves targeting TBL1X to promote genomic instability in mantle cell lymphoma. She received her MS in biochemistry and molecular biology from Indiana University and her DVM from Purdue University. She recently completed her PhD in comparative biomedical sciences and residency training in veterinary anatomic pathology at The Ohio State University.

Hedieh’s projects include developing a fully immune competent mantle cell lymphoma mouse model and characterizing the oncogenic role of TBL1X in c-Myc overexpressing diffuse large B-cell lymphoma. She received her BS in cell and molecular biology from Ferdowsi University of Mashhad, and her MS in molecular genetics from The Ohio State University.

Nile is a graduate student working on developing novel CAR T-cell therapies to treat hematological malignancies. He received his BA in genetics from Rutgers University and his MS in biomedical sciences from Icahn School of Medicine at Mount Sinai.

Dr. Nishat currently studies T-cell exhaustion/senescence in B-cell lymphoma. She received her PhD from Jamia Millia Islamia in New Delhi, India.

Dr. Tsyba’s current projects include validating transducin β-like protein 1 (TBL1) as a novel therapeutic target in diffuse large B-cell lymphoma and mantle cell lymphoma. She received her PhD from the Institute of Molecular Biology and Genetics of the National Academy of Sciences in Kyiv, Ukraine.

Dr. Palamarchuk’s current project focuses on characterizing and targeting the DNA damage response in mantle cell lymphoma. He received his PhD from the Institute of Molecular Biology and Genetics of the National Academy of Sciences in Kyiv, Ukraine.

Ethan is currently studying health sciences and biology at The Ohio State University while completing various projects in the Alinari Lab.

Danny is currently studying biochemistry at The Ohio State University while completing various projects in the Alinari Lab.

Ian is responsible for treatments, monitoring and the care of lymphoma murine models. He received his BS in animal biosciences from The Ohio State University.

Sydney is responsible for lymphoma project management and the care of lymphoma murine models. She received her BS in agricultural science and her MS in translational pharmacology from The Ohio State University.

Coinne’s role in the Alinari Lab involves maintaining the lab’s mouse colonies and monitoring murine lymphoma disease models.